KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Accounts Payables (2016 - 2026)

Medtronic's Accounts Payables history spans 13 years, with the latest figure at $2.6 billion for Q1 2026.

  • For Q1 2026, Accounts Payables rose 12.38% year-over-year to $2.6 billion; the TTM value through Jan 2026 reached $2.6 billion, up 12.38%, while the annual FY2025 figure was $2.4 billion, 1.62% up from the prior year.
  • Accounts Payables for Q1 2026 was $2.6 billion at Medtronic, roughly flat from $2.6 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.7 billion in Q2 2023 and bottomed at $2.0 billion in Q1 2022.
  • The 5-year median for Accounts Payables is $2.3 billion (2025), against an average of $2.3 billion.
  • The largest annual shift saw Accounts Payables grew 16.96% in 2023 before it decreased 9.82% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $2.2 billion in 2022, then decreased by 1.09% to $2.2 billion in 2023, then increased by 9.29% to $2.4 billion in 2024, then grew by 8.63% to $2.6 billion in 2025, then decreased by 0.46% to $2.6 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Accounts Payables are $2.6 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.6 billion (Q3 2025).